According to researchers at Marshall University, a maternal diet rich in Omega-3 fatty acids protects from breast cancer development in offspring. In a new study recently published by Frontiers in Cell and Developmental Biology, researchers noted a significant difference in mice from mothers that were fed a diet rich in canola oil, compared with mothers… Read More »
WEDNESDAY, May 19, 2021 — There’s some reassuring news for women with multiple sclerosis (MS): Having the neurological disease won’t affect health outcomes if breast cancer strikes. “Although multiple sclerosis and its complications remain the most common cause of death in people with MS, cancer is the second or third most common cause of death,”… Read More »
A Quick Look at DIEP Flap Breast Reconstruction Surgery A Quick Look at DIEP Flap Breast Reconstruction Surgery : After undergoing the mastectomy procedure, many women wonder what they can do to restore their breasts and improve their overall confidence. While there are many different treatment options available to those patients, DIEP flap breast reconstruction surgery… Read More »
Beverley Craven, a British singer-songwriter is best known for her 1991 UK hit single “Promise Me“ In 2018, Craven was diagnosed with breast cancer and underwent a double mastectomy and lymph node surgery followed by chemotherapy treatment, resulting in an interruption in her Woman to Woman tour, which was resumed in 2019 after her health… Read More »
July 10th, 2020 Medgadget Editors Ob/Gyn, Oncology, Radiology Hologic is launching in the U.S. its first cart-based breast ultrasound system, the SuperSonic MACH 40. The company touts the device as a premium ultrasound that produces high fidelity images and features a number of capabilities that improve clinical efficiency and diagnostic accuracy. Some of these features… Read More »
For metastatic breast cancer patients who try and fail on multiple treatments, finding options to manage disease is a difficult proposition. AstraZeneca and Daiichi Sankyo hoped their antibody-drug conjugate could help that tough-to-treat population––and the FDA agreed to give it a shot despite a shaky safety profile. The FDA approved AstraZeneca and Daiichi’s Enhertu (fam-trastuzumab deruxtecan-nxki) on Friday as… Read More »